EPISODE · Dec 2, 2024 · 24 MIN
Los avances en las vacunas con GSK
from Biotecnología Capital · host Capital Radio
Alberto Clemente, director del área de vacunas de GSK España, habla de la que su compañía ha desarrollado para el VRS. También de los avances que se están produciendo tras la pandemia.
Embed this episode
NOW PLAYING
Los avances en las vacunas con GSK
0:00
24:56
1×
No transcript for this episode yet
Similar Episodes
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Biotecnología Capital?
This episode is 24 minutes long.
When was this Biotecnología Capital episode published?
This episode was published on December 2, 2024.
Can I download this Biotecnología Capital episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!